Fundraising Fox

Glenn Rockman

Investor

Managing Partner at Adjuvant Capital · Board director at Codagenix · Board director at Indevr

New York, New York

Writes $100K – $5M checks · typically $1.5M

About

Glenn Rockman is Co-Founder and Partner at Adjuvant Capital, which he founded in 2018, with over 20 years of experience in venture capital and investment banking. He previously was a Managing Partner at the advisory firm managing the Global Health Investment Fund (GHIF) and an Executive Director in J.P. Morgan's Social Finance unit, where he spent more than a decade before focusing on life sciences investing. He holds an AB in public policy from the Princeton School of Public and International Affairs.

Contact· self-published, not guessed

Invests in

BiotechHealthtech

Board director at Codagenix

Intro paths

→

In turn, Glenn can intro founders to Codagenix's investors below.

Codagenix's investors · 6

Adjuvant CapitalNew York · $10M – $25M checks · since 2023Department of Agriculture (USDA)since 2015In-Q-TelTysons · $100K – $2.5M checks · since 2023National Institutes of Health (NIH)since 2014Topspin PartnersRoslyn Heights · $10M – $50M checks · since 2023U.S. Armysince 2017

Co-founders at Codagenix

JR
John Robert ColemanExecutive Officer, Director
SMSteffen Mueller
Steffen MuellerDirector

Board director at Indevr

Intro paths

→

In turn, Glenn can intro founders to Indevr's investors below.

Indevr's investors · 1

Adjuvant CapitalNew York · $10M – $25M checks

Co-founders at Indevr

KR
Kathy RowlenCo-founder, Scientific Advisor (former CEO)

Experience

  1. Adjuvant CapitalFounder and Managing Partnercurrent2018 — presentNew York
  2. Quantoom BiosciencesDirectorcurrent2025 — presentBrussels, Brussels Region, Belgium
  3. VitriVaxDirectorcurrent2020 — presentBoulder, Colorado, United States
  4. WaterEquityMember - Council of Directorscurrent2020 — present
  5. Codagenix, Inc.Directorcurrent2020 — presentFarmingdale, NY
  6. UNIVERCELLSDirector2018 — 2025Brussels Area, Belgium
  7. RIGHT FUND, Research Investment for Global Health Technology Fund FoundationDirector2018 — 2025Gwanak-gu, Seoul, Korea
  8. X-Vax Technology, Inc.Director2022 — 2023
  9. X-Vax Technology, Inc.Board Observer2019 — 2022
  10. InDevR, Inc.Director2019 — 2022Boulder, CO
  11. Global Health Investment CorporationSecretary-Treasurer2015 — 2021New York, New York, United States
  12. EuBiologics co.,LtdDirector2016 — 2021Seocho-gu, Seoul, Korea
  13. Themis Bioscience GmbHDirector2017 — 2020Vienna, Austria
  14. Global Health Investment FundCo-Managing Partner of Global Health Investment Fund's Investment Manager2014 — 2019New York, NY
  15. IanTECHDirector2017 — 2018Reno, Nevada Area
  16. Tribendimidine Finance CompanyDirector2016 — 2018
  17. Moxidectin for Onchocerciasis Company LimitedDirector2015 — 2018London, United Kingdom
  18. J.P. MorganExecutive Director, Social Finance2014New York, NY
  19. J.P. MorganVice President, Social Finance2012 — 2014Greater New York City Area
  20. J.P. MorganVice President, Higher Education / Non-Profit Investment Banking2007 — 2012Greater New York City Area
  21. Bill & Melinda Gates FoundationJ.P. Morgan Secondee2011Seattle, WA

Skills & more

Global HealthInfectious DiseasesLife SciencesImpact InvestingInvestmentsFinancial StructuringCapital MarketsInvestment BankingFinancial AnalysisEmerging MarketsNon-profitsFinancial Modeling
+12 moreFixed IncomeDerivativesRisk ManagementFinancial MarketsFinanceStart-upsVenture CapitalPortfolio ManagementBiotechnologyBiopharmaceuticalsMedical DevicesAsset Management

Languages English

From Glenn's professional profile.

Investments

Board seats

CodagenixEuBiologicsIanTechMoxidectin for Onchocerciasis LimitedUnivercellsVitriVax

Investor

IndevrThemis

Per the firm's website.

Colleagues at Adjuvant Capital

Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Jim Robinson
Senior Advisor at Adjuvant Capital

Network3

Jenny Yip
Managing Partner at Adjuvant Capital
Kabeer Aziz
Co-Founder and Partner at Adjuvant Capital
Mark Sullivan
Venture Partner at Adjuvant Capital

Investors connected to Glenn in public investor directories — a warm-intro map.

Frequently asked questions

Who is Glenn Rockman?
Glenn Rockman is Co-Founder and Partner at Adjuvant Capital, which he founded in 2018, with over 20 years of experience in venture capital and investment banking. He previously was a Managing Partner at the advisory firm managing the Global Health Investment Fund (GHIF) and an Executive Director in J.P. Morgan's Social Finance unit, where he spent more than a decade before focusing on life sciences investing. He holds an AB in public policy from the Princeton School of Public and International Affairs.
Where does Glenn Rockman work?
Glenn Rockman is Managing Partner at Adjuvant Capital and Board director at Codagenix and Board director at Indevr.
What does Glenn Rockman invest in?
Glenn Rockman invests in Biotech, Healthtech.
What check size does Glenn Rockman write?
Glenn Rockman typically writes checks of $100K – $5M.
What boards does Glenn Rockman sit on?
Glenn Rockman holds tracked board seats at Codagenix, EuBiologics, IanTech, Moxidectin for Onchocerciasis Limited, Univercells, VitriVax.
What companies has Glenn Rockman invested in?
Investments tracked here include Indevr, Themis.
Where did Glenn Rockman go to school?
Glenn Rockman studied at Princeton University (BA, The Princeton School of Public and International Affairs); The Chinese University of Hong Kong (Study Abroad, Chinese Language (Mandarin)).

Same school

Also attended Princeton University775

Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordKJ SidberryInvestor at GV (Google Ventures)AndrewAdvisor at Clear Ventures

+ 769 more

Also attended The Chinese University of Hong Kong99

Sidd SrinivasaVenture Partner at Madrona Venture GroupMadeleine GoldbergInvestor at Lerer HippeauLily RaakaStrategist at Plum Alley InvestmentsMaría de Lera AuerspergInvestor at KfundBryson HearneAssociate at ResilienceVCFiona ZhengPrincipal at Artesian

+ 93 more

Shared employers

Also worked at UNIVERCELLS2

Olivier de DuveManaging Partner and Head of Investment Services at Inventures Investment PartnersKate AntrobusOperating Partner at Adjuvant Capital

Also worked at Global Health Investment Fund4

Kabeer AzizCo-Founder and Partner at Adjuvant CapitalCurt LaBelleVenture Partner at Adjuvant CapitalWilliam GreeneVenture Partner at MPM CapitalJulia LiCEO at Micrographia Bio

Also worked at J.P. Morgan1,253

KJ SidberryInvestor at GV (Google Ventures)Rishi ModiInvestor at GV (Google Ventures)Akshat GoenkaInvestor at Moonfire VenturesNaseem MoumeneVice President at Northzone, investing across complex and fragmented industries undergoing fundamental shiftsLauren von ReynInvestor at LightbankFranklin BiGeneral Partner at Pantera Capital

+ 1,247 more